18956075901
當前位置：> 供求商機> Hey A8人卵巢癌細胞、H
| 種屬 | 人 |
| 別稱 | HEY-A8; Hey-A8; Hey A8; HEYA8; HeyA8 |
| 組織來源 | 卵巢 |
| 疾病 | 肺小細胞癌 |
| 傳代比例/細胞消化 | 1:2傳代,貼壁消化1-2分鐘 |
| 培養基配置 | DMEM培養基；10%胎牛血清；1%雙抗 |
| 形態 | 上皮細胞樣 |
| 生長特征 | 貼壁生長 |
| STR | Amelogenin X CSF1PO 10,11 D2S1338 24,25 D3S1358 16 D5S818 11,12 D7S820 12 D8S1179 13,14 D13S317 11 D16S539 8,12 D18S51 15 D19S433 13,14 D21S11 30 FGA 20,21 TH01 8,9.3 TPOX 11 vWA 16,17 |
| 倍增時間 | 每周 2 至 3 次 |
outcomes. Clinical analyses have also revealed unprecedented heterogeneity in tumor and stromal biology of PDAC, underscoring the need for more personalized approaches and combinatorial therapies. This review will highlight the current state of translational research focusing on PDAC immunity, summarize ongoing clinical efforts to tackle PDAC vulnerabilities, and underscore some unresolved challenges in implementing therapies more broadly. A better
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供，信息內容的真實性、準確性和合法性由相關企業負責，化工儀器網對此不承擔任何保證責任。
溫馨提示：為規避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。
